Humanly
Humanly is a comprehensive, AI-driven recruiting platform that revolutionizes the talent acquisition process by automating and orchestrating the entire candidate journey. Featuring an all-in-one CRM combined with agentic AI, it supports high-volume hiring needs through intelligent sourcing, 24/7 personalized outreach via SMS and email, automated pre-screening chats, and effortless scheduling. The platform leverages a vast 600 million candidate database and advanced AI sourcing technology to find the best-fit talent efficiently. Humanly’s automation tools engage candidates with a human-like touch, significantly reducing time-to-hire by up to eight times while improving recruiter productivity and candidate experience. Seamless integration with applicant tracking systems ensures smooth workflows, while robust analytics provide data-driven insights for better recruitment strategies. Users can eliminate scheduling friction with automated reminders and calendar management, preventing missed opportunities. Recruiters appreciate the platform’s intuitive design and exceptional customer support. Humanly has earned a 4.8/5 rating on G2, trusted by top companies and recruiting professionals worldwide. The platform enables talent teams to scale efficiently, reduce no-shows, increase pipeline diversity, and make informed decisions with ease. Humanly is the future of efficient, scalable, and candidate-centric recruiting.
Learn more
Visual Visitor
AI Sales Representative - Your Future Sales Agent May Not Be Human at All
Transform your engaged website visitors into sales-ready leads without dedicating even a single working hour.
Using our cutting-edge WebID + Person identification technology, we target the most engaged visitors on your site, focusing on those who can provide the greatest value to your sales initiatives.
- Comprehensive Prospect Information: We collect 40 essential data points for each prospect, including their first name, last name, email address, and more.
- Engaged Yet Unidentified: These prospects are actively researching online but haven't yet interacted with your sales team.
- Key Position in the Sales Funnel: These visitors are well into your sales funnel, spending significant time on your crucial 'buying pages' while remaining anonymous, making them prime candidates for conversion into appointments.
- AI-Powered Engagement: Our AI Sales Rep adeptly identifies and engages these visitors, encouraging them to show interest in your offerings. This entire process is automated, allowing your sales team to focus solely on the leads that are most likely to convert—your accessible opportunities.
By harnessing AI, you can seamlessly convert your website visitors into leads that are ready for meetings, all while enhancing efficiency in your sales process.
Learn more
Recursion
Recursion is a pioneering TechBio company reimagining drug discovery through the integration of biology, artificial intelligence, and large-scale data. Founded more than ten years ago, Recursion introduced a novel approach that uses cellular imaging to train AI models to understand disease mechanisms. The company’s mission is to reduce the high failure rate of traditional drug development by uncovering deeper biological insights. At the core of its work is the Recursion OS, a drug discovery and development platform that unifies data, machine learning, and automated experimentation. Recursion has built one of the world’s largest proprietary biological and chemical datasets, spanning phenomics, transcriptomics, proteomics, and patient data. Its automated wet labs generate millions of experiments weekly, creating a continuous feedback loop that improves model performance. This system enables rapid identification of new drug targets and optimized molecule design. Recursion’s pipeline includes multiple programs addressing aggressive cancers and rare diseases with significant unmet needs. The company partners with pharmaceutical leaders, computational technology providers, and data innovators to extend its impact. With BioHive-2, a powerful supercomputer built with NVIDIA, Recursion processes massive datasets at unprecedented speed. These capabilities allow the company to move candidates faster from discovery to clinical trials. Overall, Recursion is focused on delivering better medicines to patients through AI-driven precision and scale.
Learn more
BenevolentAI
BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.
Learn more